Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 2 评价芎龙止痛鼻喷雾剂治疗偏头痛急性发作(瘀血阻络证)有效性和安全性的随机、双盲、安慰剂对照的Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of Xionglong analgesic nasal spray in the treatment of acute migraine (blood stasis and obstruction syndrome)
(1)评价芎龙止痛鼻喷雾剂治疗偏头痛急性发作(瘀血阻络证)的有效性;
(2)评价芎龙止痛鼻喷雾剂治疗偏头痛急性发作(瘀血阻络证)的安全性。
[Translation] (1) To evaluate the effectiveness of Xionglong analgesic nasal spray in the treatment of acute migraine attacks (blood stasis and obstruction of collaterals syndrome);
(2) To evaluate the safety of Xionglong analgesic nasal spray in the treatment of acute migraine attacks (blood stasis and obstruction of collaterals syndrome).
100 Clinical Results associated with Beijing Yikangtai Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Yikangtai Technology Co., Ltd.
100 Deals associated with Beijing Yikangtai Technology Co., Ltd.
100 Translational Medicine associated with Beijing Yikangtai Technology Co., Ltd.